Takafumi Etoh
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Characterization of Prurigo Nodules in Adults With Moderate-To-Severe Atopic Dermatitis in Japan: A 2-Year Observational Study.
Journal: The Journal of dermatology
Published: September 09, 2025
An unbiased tissue transcriptome analysis identifies potential markers for skin phenotypes and therapeutic responses in atopic dermatitis.
Journal: Nature communications
Published: February 06, 2024
Correlation Analysis of Clinician- and Patient-Reported Outcomes Among Japanese Adults with Atopic Dermatitis.
Journal: Dermatology and therapy
Published: October 16, 2023
Efficacy of Integrated Online Mindfulness and Self-compassion Training for Adults With Atopic Dermatitis: A Randomized Clinical Trial.
Journal: JAMA dermatology
Published: May 10, 2023
Evaluation of standard treatments for managing adult Japanese patients with inadequately controlled moderate-to-severe atopic dermatitis: Two-year data from the ADDRESS-J disease registry.
Journal: The Journal of dermatology
Published: November 11, 2021
Papular acantholytic dyskeratosis in a male patient localized to the anogenital area mimicking condyloma acuminatum.
Journal: The Journal of dermatology
Published: September 08, 2021
Dupilumab Maintains Long-Term Disease Control in Adults with Moderate-to-Severe Atopic Dermatitis as Measured by Well-Controlled Weeks: Results From the LIBERTY AD CHRONOS Clinical Trial.
Journal: Dermatology and therapy
Published: November 19, 2020
Japanese guidance for use of biologics for psoriasis (the 2019 version).
Journal: The Journal of dermatology
Published: November 23, 2019
Efficacy and safety of dupilumab in Japanese adults with moderate-to-severe atopic dermatitis: a subanalysis of three clinical trials.
Journal: The British journal of dermatology
Published: September 25, 2019
Atopic dermatitis disease registry in Japanese adult patients with moderate to severe atopic dermatitis (ADDRESS-J): Baseline characteristics, treatment history and disease burden.
Journal: The Journal of dermatology
Published: October 04, 2018
Nemolizumab in patients with moderate-to-severe atopic dermatitis: Randomized, phase II, long-term extension study.
Journal: The Journal of allergy and clinical immunology
Published: September 19, 2017
Last Updated: 09/26/2026